ATPC logo

AGAPE ATP CORP

ATPCNASDAQ
πŸ† #5342 by market capUS Equity
$2.17β–Ό $0.03 (βˆ’1.36%)
Live
πŸ””
Track ATPC
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 1.4%
7dβ–Ό 6.5%
14dβ–Ό 6.1%
30dβ–Ό 9.2%
ytdβ–Ό 58.1%
1yβ–Ό 96.6%
🏦Market Cap
$2M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+15.2%
Healthy
πŸ“ŠGross Margin
58.9%
Healthy
πŸ’΅FCF Margin
-91.8%
Thin
βš–οΈP/S Ratio
2.1x
Cheap
Otter Score
52
Weak

Trading Snapshot

Day Range
$2.14 – $2.19
52-Week Range
$1.72 – $73.50
Volume
$2.28B
Avg Volume
$2.27B
Shares Outstanding
1.0M
Next Earnings
Dec 1, 2026

Fundamentals Snapshot

Annual Revenue
$2M
Last Q Revenue
$13,693
P/E Ratio
-1.9
P/S Ratio
2.1x
EPS (TTM)
$-1.14
Dividend Yield
0.00%
Dilution (1yr)
βˆ’36.9%

Why Investors Own ATPC

  • βœ“High-growth profile β€” revenue up +14.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 31% gross margin and 5% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ATPC logo

AGAPE ATP CORP

ATPC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$2Mβ–² +15.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
53.7%β–Ό βˆ’6.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$3Mβ–² +26.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$2Mβ–Ό βˆ’13.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
801Kβ–Ό βˆ’36.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$90Kβ–Ό βˆ’$2M YoY
StockOtter Β· stockotter.space

About AGAPE ATP CORP

Agape ATP Corporation, an investment holding enterprise, operates out of Malaysia, providing a variety of health and wellness products in addition to health solution advisory services. The company structures its extensive offerings into four main program categories: ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S., each encompassing a unique selection of goods and services. Its product range includes the ATP series, featuring ATP1s Survivor Select for essential bodily nutrients, ATP3 Ionized Cal-Mag as a vital calcium and magnesium supplement, ATP4 Omega Blend supplying crucial omega 3 and 6 fatty acids, and ATP5 BetaMaxx for immune system enhancement. Other products in this line address specific needs, such as AGN-Vege Fruit Fiber for digestive tract health, AGP1-Iron to combat iron deficiency, and YFA-Young Formula for anti-aging and youthful appearance maintenance. Under the BEAUNIQUE brand, consumers can find Mito+, an antioxidant beverage formulated for cellular, immune, metabolic, brain, and skin health, alongside Trim+, which works to inhibit carbohydrate digestion and reduce sugar absorption. The ÉNERGÉTIQUE brand specializes in skincare, offering various energy masks (Med-Hydration, Med-Whitening, Med-Firming), a hyaluronic acid serum, and a mousse facial cleanser. Additionally, the company markets soy protein isolate powder and an antioxidant under the Livo5 label. Beyond its product sales, Agape ATP Corporation actively advocates for a healthy lifestyle through online articles, structured programs, events, and public campaigns, while also delivering therapeutic health services. The company was founded in 2016 and maintains its corporate headquarters in Kuala Lumpur, Malaysia.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
52/100

Analyst Price Target

β“˜
Average Target
$2.82
β–² +29.8% Upside
High Target$3.47
Low Target$2.18
Based on 15 analysts

Latest News & Updates